Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

BNT162 Vaccine × Lymphoid × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 140 Rituximab 138 venetoclax 80 Specimen Handling 74 Vincristine 71 fludarabine 65 Prednisone 64 Doxorubicin 64 Magnetic Resonance Spectroscopy 61 Biopsy 59 obinutuzumab 53 Lenalidomide 45 ibrutinib 41 Cytarabine 41 Methotrexate 38 Dexamethasone 38 fludarabine phosphate 34 zanubrutinib 33 acalabrutinib 33 CT-P10 33 Etoposide 32 blinatumomab 28 Bendamustine Hydrochloride 28 glofitamab 26 prednylidene 25 pembrolizumab 25 deltacortene 25 Gemcitabine 24 pirtobrutinib 21 polatuzumab vedotin 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡